Skip to main content
Xiaoguang Liu, MD, Physical Medicine/Rehab, New York, NY, BronxCare Health System

XiaoguangLiuMD

Physical Medicine/Rehab New York, NY

Hospice & Palliative Medicine

Physician

Are you Dr. Liu?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Connect with colleagues in the same hospital or clinic
    You already have 29 invites waiting!
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Summary

  • Dr. Xiaoguang Liu, MD is a physiatrist in New York, New York. He is currently licensed to practice medicine in New York, Missouri, and New Jersey. He is affiliated with BronxCare Health System and NYC Health + Hospitals / Harlem.

Education & Training

  • SUNY Downstate Health Sciences University
    SUNY Downstate Health Sciences UniversityResidency, Physical Medicine and Rehabilitation, 2005 - 2007
  • Kingsbrook Jewish Medical Center
    Kingsbrook Jewish Medical CenterResidency, Physical Medicine and Rehabilitation, 2003 - 2004
  • Westchester Medical Center
    Westchester Medical CenterResidency, Surgery, 2001 - 2003
  • Montefiore Medical Center/Albert Einstein College of Medicine
    Montefiore Medical Center/Albert Einstein College of MedicineResidency, Surgery, 1999 - 2000
  • Norman Bethune University of Medical Sciences
    Norman Bethune University of Medical SciencesClass of 1982

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2007 - Present
  • NY State Medical License
    NY State Medical License 2004 - 2026
  • NJ State Medical License
    NJ State Medical License 2007 - 2019
  • MO State Medical License
    MO State Medical License 2015 - 2016
  • American Board of Physical Medicine and Rehabilitation Physical Medicine & Rehabilitation

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Inhibiting USP13 Destroys Alpha-Synuclein in Parkinson’s Model
    Inhibiting USP13 Destroys Alpha-Synuclein in Parkinson’s ModelNovember 16th, 2018

Hospital Affiliations